RT @asouth_neph: Better study design and analytic methods, will be up on @NephJC site Inpatient Use of #ACEi and #ARB and Mortality Amo…
RT @paomorejon: Quedaría mejor si le cambiamos un poco❓❤️ “Al menos daño no hacen” Difícil llegar a esa conclusión al ser retrospectivo ob…
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @kharaguchi: https://t.co/rP49Ujn1U7 【Use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @ABsteward: Surprising! @CircRes @CircAHA Among hospitalized COVID-19 patients with hypertension, inpatient use of ACEI/ARB was associat…
RT @headachedoc: If you’re considering which #migraine preventive start for your patient, it might be time for candesartan or lisinopril.…
RT @DailyRounds: An infographic on the latest update on the use of ACEIs and ARBs in hypertensive patients with COVID-19 from @American_Hea…
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
@GabbGenevieve @ANZSN @ASCEPTanz @thebyrdlab @CDRMR1 @MJA_Editor mortality benefit with RAS agents in #COVID consistent with @KingsCollegeLon and other data from China.
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @MartinQuirosMD: Análisis retrospectivo de pacientes que tomaban IECA/ARAII (publicado en Circulation). Se asoció con < mortalidad. L…
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
@hamid_safdari @DrWaheedArian @ShoaibAmini2 not much data out there yet, but here is small study https://t.co/IES3ztZofy
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @ABsteward: Surprising! @CircRes @CircAHA Among hospitalized COVID-19 patients with hypertension, inpatient use of ACEI/ARB was associat…
RT @EmilioOrtegaMdV: IECA/ARA2: menor mortalidad en pacientes ingresados por COVID19. Mejor calidad de estudio diferentes noticias. Circula…
RT @EmilioOrtegaMdV: IECA/ARA2: menor mortalidad en pacientes ingresados por COVID19. Mejor calidad de estudio diferentes noticias. Circula…
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
Very interesting data
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
@Yzma37 https://t.co/IACTVly7Tt And https://t.co/xVebPCGcvk It makes sense because the virus does attach to human ACE2 receptors
RT @EmilioOrtegaMdV: IECA/ARA2: menor mortalidad en pacientes ingresados por COVID19. Mejor calidad de estudio diferentes noticias. Circula…
RT @catcardiocamfic: En pacients hospitalitzats amb #COVID19 amb HTA, l’us d’IECA/ARA2 es va associar a menor mortalitat que en els que no…
I understand it is not an RCT but is anyone else excited by the possibility that ACEi/ARBs may confer mortality benefit in #COVID19?!!! I am already a big fan of these drugs, and now they may save lives in the time of COVID. What?!!! 🤣 I am such a nerd.
RT @HashemGhaili: - Ultomiris: https://t.co/RyqbhSfNaO - Stockholm: https://t.co/MzzpdQCqhD - ACE inhibitors: https://t.co/xZXJchQxqZ -…
- Ultomiris: https://t.co/RyqbhSfNaO - Stockholm: https://t.co/MzzpdQCqhD - ACE inhibitors: https://t.co/xZXJchQxqZ - ACE inhibitors (2): https://t.co/UenntMhMfB - Los Angeles: https://t.co/erga53owlW #COVID_19 #COVID19 #CoronavirusUpdates
RT @catcardiocamfic: En pacients hospitalitzats amb #COVID19 amb HTA, l’us d’IECA/ARA2 es va associar a menor mortalitat que en els que no…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @EMBoardBombs: FINALLY- logic prevails... Stop taking pts off their ACEB/ARBs. We wait for good data to make big decisions #meded #thisi…
RT @catcardiocamfic: En pacients hospitalitzats amb #COVID19 amb HTA, l’us d’IECA/ARA2 es va associar a menor mortalitat que en els que no…
RT @catcardiocamfic: En pacients hospitalitzats amb #COVID19 amb HTA, l’us d’IECA/ARA2 es va associar a menor mortalitat que en els que no…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @SantasEnrique: Datos que de nuevo refuerzan NO suspender IECA/ARA-2 en pacientes con HTA 🏥 por #COVID19. Menor riesgo de mortalidad e…
RT @catcardiocamfic: En pacients hospitalitzats amb #COVID19 amb HTA, l’us d’IECA/ARA2 es va associar a menor mortalitat que en els que no…
RT @MartinQuirosMD: Análisis retrospectivo de pacientes que tomaban IECA/ARAII (publicado en Circulation). Se asoció con < mortalidad. L…
RT @MartinQuirosMD: Análisis retrospectivo de pacientes que tomaban IECA/ARAII (publicado en Circulation). Se asoció con < mortalidad. L…
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @ABsteward: Surprising! @CircRes @CircAHA Among hospitalized COVID-19 patients with hypertension, inpatient use of ACEI/ARB was associat…
RT @gsmartinmd: *Important news: in #COVID19 patients from Hubei, those taking ACE-inhibitors or ARB's had lower mortality https://t.co/5S…
RT @PrXavierGirerd: Diminution de 60% de la mortalité par #COVID19 chez les patients ayant une #hypertension artérielle par l'utilisation…
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
@__ice9 @__philipn__ @cjtign ACEi/ARBs associated with lower morbidity - larger study from China https://t.co/SQEGLiUfRk
RT @catcardiocamfic: En pacients hospitalitzats amb #COVID19 amb HTA, l’us d’IECA/ARA2 es va associar a menor mortalitat que en els que no…
RT @catcardiocamfic: En pacients hospitalitzats amb #COVID19 amb HTA, l’us d’IECA/ARA2 es va associar a menor mortalitat que en els que no…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @EmilioOrtegaMdV: IECA/ARA2: menor mortalidad en pacientes ingresados por COVID19. Mejor calidad de estudio diferentes noticias. Circula…
RT @catcardiocamfic: En pacients hospitalitzats amb #COVID19 amb HTA, l’us d’IECA/ARA2 es va associar a menor mortalitat que en els que no…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @DavidJuurlink: Wow. Among patients hospitalized with COVID, strikingly *lower* mortality for those on an ACEi/ARB On an ACEi/ARB: 3.7%…
RT @Nat_anest: Интересное ретроспективное исследование по ингибиторам АПФ и Covid - 1128 пациентов из 9 госпиталей: *в группу принимающих…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
Saurav, a different dataset with larger sample size and much more rigorous PS matching and sensitivity analysis would be helpful.
RT @SharkawyMD: Interesting. Another example of being careful not to impune a whole class of useful drugs based on a hypothesis alone.
Interesting. Another example of being careful not to impune a whole class of useful drugs based on a hypothesis alone.
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @gsmartinmd: *Important news: in #COVID19 patients from Hubei, those taking ACE-inhibitors or ARB's had lower mortality https://t.co/5S…
RT @Nat_anest: Интересное ретроспективное исследование по ингибиторам АПФ и Covid - 1128 пациентов из 9 госпиталей: *в группу принимающих…
RT @gsmartinmd: *Important news: in #COVID19 patients from Hubei, those taking ACE-inhibitors or ARB's had lower mortality https://t.co/5S…
*Important news: in #COVID19 patients from Hubei, those taking ACE-inhibitors or ARB's had lower mortality https://t.co/5S3otxFrjk
RT @catcardiocamfic: En pacients hospitalitzats amb #COVID19 amb HTA, l’us d’IECA/ARA2 es va associar a menor mortalitat que en els que no…
RT @KaminskiMed: Convincing? Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers…
Интересное ретроспективное исследование по ингибиторам АПФ и Covid - 1128 пациентов из 9 госпиталей: *в группу принимающих ингибиторы АПФ или блокаторы рецепторов ангиотензионогена 2 вошло 188 больных * В группу без них - 940 https://t.co/02gtTnp0n6
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
RT @kharaguchi: https://t.co/rP49Ujn1U7 【Use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
Joli topo mêlant actualité médicale et cours de LCA, ça permet de voir si on reste au point après les ECN.
RT @PrXavierGirerd: Diminution de 60% de la mortalité par #COVID19 chez les patients ayant une #hypertension artérielle par l'utilisation…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @kharaguchi: https://t.co/rP49Ujn1U7 【Use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs…
RT @catcardiocamfic: En pacients hospitalitzats amb #COVID19 amb HTA, l’us d’IECA/ARA2 es va associar a menor mortalitat que en els que no…
RT @EmilioOrtegaMdV: IECA/ARA2: menor mortalidad en pacientes ingresados por COVID19. Mejor calidad de estudio diferentes noticias. Circula…
https://t.co/rP49Ujn1U7 【Use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) is a major concern for clinicians treating coronavirus disease 2019 (COVID-19) in patients with hypertension】ACEIs− ARBsが治療予後に有効か?こ
RT @statsepi: Be mindful of potential collider bias here. It's not just patients with COVID-19 - it's patients with that *and* hypertension.
RT @LChouchana: Analyse d'un article sur le rôle des IEC/ARA2 sur la gravité du #COVID19 Hot topic !
RT @influenzer3: ●ACEI/ARBの使用はCOVID-19における予後良好因子 →これが三報目でかつ決定版かと。 もうこれについては決着がついたと言えるように思います。 https://t.co/DkbC4lpprr
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
RT @DrRoderickTung: Nice illustration of how initial speculation based on isolated physiological upregulation of ACE2 may actually be the…
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…
Analyse d'un article sur le rôle des IEC/ARA2 sur la gravité du #COVID19 Hot topic !
RT @salvacuesta: La (cada vez más) inestable evidencia
RT @srrezaie: IMPORTANT STUDY --> Zhang P et al. Association of Inpatient Use of ACEI/ARBs with 28d Mortality Among Pts with HTN Hospitaliz…